News
QTNTQ
0.039
NaN%
--
Quotient Is becoming AliveDx
Benzinga · 10/30/2023 12:30
More
Webull provides a variety of real-time QTNTQ stock news. You can receive the latest news about Quotient through multiple platforms. This information may help you make smarter investment decisions.
About QTNTQ
Quotient Limited is a Switzerland-based diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It is engaged in developing MosaiQ, which is its technology platform. The Company develops, manufactures and commercializes the products, including antisera products, reagent red blood cells, whole blood controls and ancillary products. Additionally The Company develops, manufactures and sells conventional reagent products to original equipment manufacturers (OEMs).